Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01948947 · ClinicalTrials.gov registry record · NA

Improving Functions in MTBI Patients With Headache by rTMS

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT01948947: Completed NA study, sponsored by VA Office of Research and Development.

NCT01948947 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01948947, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

Due to recent wars in Afghanistan and Iraq, the number of Veteran suffering from Mild traumatic brain(MTBI) injury and PTSD increases rapidly. Headache is one of the most debilitating clinical symptoms in Veteran with MTBI and the cause of it is still not entirely clear. Recently, the use of non-invasive brain stimulation such as repetitive transcranial magnetic stimulation(rTMS) has yielded favorable clinical outcome in a few intractable chronic central pain conditions including headaches. This study aims to 1) assess the effect of rTMS in relieving headache and improving neurophysiological functions; and 2)explore the neuronal mechanisms associated with MTBI related headache and the analgesic effect of rTMS with function magnetic resonance imaging (fMRI).

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • DEVICE Sham Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-05
Est. Completion 2016-09
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01948947

The ClinicalTrials.gov registry entry for NCT01948947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT01948947 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01948947 about?

NCT01948947 is a clinical study titled "Improving Functions in MTBI Patients With Headache by rTMS". Due to recent wars in Afghanistan and Iraq, the number of Veteran suffering from Mild traumatic brain(MTBI) injury and PTSD increases rapidly. Headache is one of the most debilitating clinical symptoms in Veteran with MTBI and the cause of it is still not entirely clear. Recently, the use of non-inv...

What is the current status of trial NCT01948947?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-05. Estimated completion is 2016-09.

What interventions are being tested in trial NCT01948947?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Sham Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT01948947?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.